Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GNMX vs. VHT: which is better?

Bottom line

GNMX vs VHT: the short answer

GNMX (Corgi Genomics & Precision Medicine ETF) and VHT (Vanguard Health Care Index Fund) are both etfs.

Updated Nov 19, 2026

GNMX vs VHT side by side

GNMXVHT
TypeETFETF
Fund familyCorgi Genomics & Precision MedicineVanguard
CategoryHealth Care SectorHealth Care Sector
Expense ratio—0.09%
Annual cost per $10k—$9
10-yr cost on $10k (prospectus)—$115
Max front loadNoneNone
12b-1 fee—0%
1-yr return—+2.7%
5-yr return (annualized)—+7.2%
10-yr return (annualized)—+8.8%
Best quarter—+16.5%
Worst quarter—−13.1%
Net assets (fund)—$19.0B
Number of holdings—407
Portfolio turnover—4%
Returns as of—Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

GNMX and VHT share none of their top holdings.

GNMX top 10

    VHT top 10

    1. Eli Lilly & Co — 14.04%
    2. Johnson & Johnson — 8.47%
    3. AbbVie Inc — 6.09%
    4. UnitedHealth Group Inc — 5.45%
    5. Merck & Co Inc — 4.66%
    6. Thermo Fisher Scientific Inc — 2.93%
    7. Amgen Inc — 2.87%
    8. Gilead Sciences Inc — 2.64%
    9. Intuitive Surgical Inc — 2.38%
    10. Pfizer Inc — 2.35%

    FAQ

    What is the difference between GNMX and VHT?
    GNMX (Corgi Genomics & Precision Medicine ETF) and VHT (Vanguard Health Care Index Fund) are both etfs.
    Should I own both GNMX and VHT?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.